Passage Bio, Inc.
PASG
$8.49
$0.465.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.21% | 25.75% | 24.84% | 36.54% | 38.78% |
| Total Depreciation and Amortization | -59.92% | -45.13% | -30.23% | -17.20% | -17.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.47% | 69.26% | 53.18% | 20.45% | -45.10% |
| Change in Net Operating Assets | -36.08% | 94.42% | 70.07% | -175.33% | -131.81% |
| Cash from Operations | 43.29% | 49.02% | 42.64% | 38.73% | 28.68% |
| Capital Expenditure | 57.58% | -100.00% | 71.67% | 76.71% | 94.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.85% | 20.15% | -0.89% | -15.91% | -10.90% |
| Cash from Investing | 10.28% | 22.21% | 0.08% | -15.77% | -9.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.31% | -99.31% | -98.51% | 6,473.33% | 5,776.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.31% | -99.31% | -98.51% | 6,473.33% | 1,878.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,691.38% | 695.11% | 681.65% | 223.05% | 95.56% |